[New therapeutic agents in immunologic idiopathic thrombocytopenic purpura treatment: thrombopoietin receptor agonists].
Khellaf
Mehdi
M
Chu Henri Mondor, Université Paris 12, Service de Médecine Interne, 51, avenue du Maréchal de Tassigny 94010 Créteil cedex, France.
D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000276:immunology / Q000628:therapy*; D011961:Receptors, Fc / Q000627:therapeutic use*; D053628:Receptors, Thrombopoietin / Q000819:agonists*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D013926:Thrombopoietin / Q000737:chemistry / Q000627:therapeutic use*
D015507:Drugs, Investigational; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; C082218:MPL protein, human; D013926:Thrombopoietin; C488777:romiplostim